Claim Missing Document
Check
Articles

Found 31 Documents
Search

Characteristics of Leprosy Chemoprophylaxis Recipeints in The Tirtayasa Public Health Center Area, 2023–2024 Imaroh, Rifa; Lumaksono, Maria Angela; Imani, Izzah; Widasmara, Dhelya
Jurnal Epidemiologi Kesehatan Indonesia
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Leprosy remains a public health problem in Indonesia. In 2023, Indonesia ranked third globally in the number of leprosy cases, with 14,376 reported cases, after India (107,851 cases) and Brazil (22,773 cases). One of the key strategies for leprosy control in Indonesia is the implementation of preventive measures, including home visits and the administration of chemoprophylaxis using single-dose rifampicin (SDR). Post-exposure prophylaxis plays an important role in preventing leprosy transmission among contacts of confirmed patients. This study aimed to describe the characteristics of leprosy chemoprophylaxis recipients in the Tirtayasa Public Health Center area during 2023–2024. This study was an descriptive observational study. A total of 381 respondents were included using total sampling from close contacts of leprosy patients who received chemoprophylaxis. Data were analyzed descriptively. The majority of chemoprophylaxis recipients were aged ≥15 years (328 individuals; 86.1%). Most recipients were female (198 individuals; 52.0%). The highest number of recipients was found in Tirtayasa Village (81 individuals; 21.3%). Based on the type of contact, most recipients had neighbor contact (237 individuals; 62.2%). The most commonly administered rifampicin dose was 600 mg (326 individuals; 85.6%). No adverse effects were reported among all recipients following rifampicin administration. Most leprosy chemoprophylaxis recipients were aged ≥15 years and female. The majority of recipients resided in Tirtayasa Village and had neighbor contact with leprosy patients. Rifampicin at a dose of 600 mg was the most frequently administered, and no adverse effects were observed among all recipients. Keywords: Characteristics, Chemoprophylaxis, Leprosy
Co-Authors Abdul Gofur Ade Setyagraha Adya Sitaresmi Agnes Sri Siswati Agung Minto Wahyu Angela Lumaksono, Maria Anggun Putri Yuniaswan Anum, Qaira Bagus Haryo Kusumaputra Cita Rosita Sigit Prakoeswa Dani, Adinda Amalia Dea Florensia Didik Hariyono Dwi Murtiastutik Fifa Argentina Fuzianingsih, Eka Noviya Haidar Abror Firladi Hansel Hansel Hardiati, Rien Henggar Sulistiarto Herwinda Brahmanti I Wayan Agung Indrawan Ika Andrini Farida Imani, Izzah Imaroh, Rifa Jayawarsa, A.A. Ketut Johan, Christopher Kuncoro Kurnia Penta Seputra Kuswantoro Rusca Putra Lita Setyowatie, Lita Lubis, Ramona Sari Luh Made Mas Rusyati Lumaksono, Maria Angela M. Yulianto Listiawan Mamuaja, Enricco Hendra Maulidah Maulidah Medhi Denisa Alinda, Medhi Denisa Mochammad Yunus, Mochammad Mohammad Bisri Muchtar, Vitayani Mulianto, Nur Rachmat Nanik Setijowati Novita, Khuznita Dasa Nugrahanti Prasetyorini Oktavia Eka Puspita, Oktavia Eka Oktavia Rahayu Adianingsih Panji Sananta Qurrotuain, Iffah rahmah, shofi nur Rakhmaditya Dewi Noorrizki Ravsanjani, Eurica Andriani Najwa Regitta Indira Agusni Renni Yuniati Ristiawan Muji Laksono Rizka Melina Fauziyyah Saitama, Akbar Sanata, Panji Santosa Basuki Santosa Basuki Sari, Diane Tantia Sari, Diane Tantia Saviestya, Kaorie Bunga Septina Yosephine Servasius To’o Jala Mulu Shahdevi Nandar Kurniawan, Shahdevi Nandar Siti Umi Ernawati Sri L. Menaldi Sunarso Suyoso Sunarso Suyoso, Sunarso Suparno Adi Santika Sutiyono, Bershiella Amandari Tamadi, Virginia Rosa Tasya Yuni Ariskasari Titin Andri Wihastuti Tutut Chusniyah VALENTINA YURINA Widarson Widhiastuti, Fitriani Widiatmoko, Arif Widodo Mardi Santoso, Widodo Mardi Wildan Faza Pratama Yuniati, Wahyu